Search Results - "melanoma"
Suggested Topics within your search.
Suggested Topics within your search.
- therapy
- Melanoma 5
- Immunotherapy 4
- immunology 4
- Neoplasms 3
- methods 3
- therapeutic use 3
- Antibodies, Monoclonal 2
- Antineoplastic Agents 2
- Cancer 2
- Immunological aspects 2
- Adjuvants, Immunologic 1
- Adoptive Transfer 1
- Antigen Presentation 1
- Antigens, Viral 1
- Antineoplastic agents 1
- CD8-Positive T-Lymphocytes 1
- CTLA-4 Antigen 1
- Cancer Vaccines 1
- Cancer vaccines 1
- Cell Cycle Checkpoints 1
- Drug targeting 1
- Genes, ras 1
- Granulocyte-Macrophage Colony-Stimulating Factor 1
- Herpesvirus 1, Human 1
- Immunotherapy, Adoptive 1
- Indicators and Reagents 1
- Melanocytes 1
- Neoplasm Proteins 1
- Oncolytic Virotherapy 1
-
1
Disorders of pigmentation melanoma /
Published 2014Table of Contents: “…Contents: Melanocyte development -- Key factors regulating lineage development -- Relationships to pigmentation diseases -- MITF -- IV-induced pigmentation -- Melanoma-genesis -- Melanoma oncogene discovery -- BRAF-targeted therapy -- Immunotherapy -- Red pigment and melanoma-genesis.…”
Get full text
Series
Electronic Video -
2
RAS and RAF signaling in melanoma biology and therapies /
Published 2010Table of Contents: “…Contents: Melanoma -- BRAF and RAS mutated in approximately 70% of cases -- Mouse models of melanoma -- Oncogenic BRAF can be a founder mutation in melanoma -- Mouse models replicate human disease -- BRAF inhibitors induce paradoxical activation of CRAF and drive pathway activation -- Kinase-dead BRAF mimics this and potentiates RAS ooncogenesis -- BRAF inhibitors induce excellent responses in patients, but may induce mechanism-based side effects through CRAF.…”
Get full text
Series
Electronic Video -
3
Immune checkpoint blockade in melanoma
Published 2017Table of Contents: “…Contents: Checkpoint inhibition in melanoma -- Immunotherapy in the adjuvant setting -- Biomarkers of immune response -- The future of immunotherapy in melanoma -- Targeting release of cancer antigens -- Targeting cancer antigen presentation -- Targeting priming and activation of the immune system -- Targeting trafficking and infiltration of T-cells -- Targeting recognition and killing of cancer cells.…”
Get full text
Series
Electronic Video -
4
Cancer vaccines part 1 of 2 /
Published 2015Table of Contents: “…Contents: The hallmarks of cancer -- Categories of cancer-associated antigens -- Viral & non-viral cancers: vaccine targets -- Immunotherapeutics -- Immunologic reagents approved for cancer therapy -- Clinical outcome based on immune response -- CTL-based therapy -- Virus-specific CTL adoptive transfer therapy -- Immunotherapy for Melanoma.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)
Electronic Video -
5
Talimogene laherparepvec first-in-class oncolytic immunotherapy /
Published 2016Table of Contents: “…Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.…”
Get full text
Series
Electronic Video -
6
Checkpoint blockade in cancer immunotherapy
Published 2007Table of Contents: “…Contents: Activation of naive T-cells -- CD28 and CTLA-4 -- Differential regulation of T-cell responses -- Responding repertoire -- Biological role of CTLA-4 -- Tumor-specific immune responses -- Treg activity -- CTLA-4/GVax -- Immunotherapies -- Conventional therapies -- Ipilumumab -- Clinical studies: melanoma -- Reversible immune mediated toxicity.…”
Get full text
Series
Electronic Video